Hawkins, Inc. (NASDAQ: HWKN) is a Basic Materials company in the Chemicals - Specialty industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 33.40 | EPS (ttm) | 3.89 | Insider Own | 5.84% | Shs Outstand | 20.88M | Perf Week | 1.47% |
| Market Cap | 2.71B | Forward P/E | 27.60 | EPS next Y | 4.71 | Insider Trans | 0.00% | Shs Float | 19.14M | Perf Month | -2.33% |
| Enterprise Value | 2.96B | PEG | - | EPS next Q | 1.26 | Inst Own | - | Short Float | 5.87% | Perf Quarter | -22.21% |
| Income | 81.09M | P/S | 2.45 | EPS this Y | 9.42% | Inst Trans | - | Short Ratio | 6.71 | Perf Half Y | -0.05% |
| Sales | 1.11B | P/B | 4.92 | EPS next Y | 11.43% | ROA | 8.01% | Short Interest | 1.12M | Perf YTD | -8.55% |
| Book/sh | - | P/C | 18.24 | EPS next 5Y | 11.43% | ROE | 15.30% | 52W High | 187.68 -30.21% | Perf Year | -23.84% |
| Cash/sh | - | P/FCF | 29.58 | EPS past 3/5Y | 10.99% 15.17% | ROIC | 9.53% | 52W Low | 118.95 10.11% | Perf 3Y | 182.41% |
| Dividend Est. | 0.80 (0.61%) | EV/EBITDA | 16.94 | Sales past 3/5Y | 5.05% 12.67% | Gross Margin | 22.30% | Volatility | 3.23% 3.81% | Perf 5Y | 257.78% |
| Dividend TTM | 0.76 (0.58%) | EV/Sales | 2.68 | EPS Y/Y TTM | -4.22% | Oper. Margin | 10.31% | ATR (14) | 5.87 | Perf 10Y | 500.88% |
| Dividend Ex-Date | Aug 14, 2026 | Quick Ratio | 1.54 | Sales Y/Y TTM | 13.55% | Profit Margin | 7.29% | RSI (14) | 36.95 | Recom | 2.50 |
| Dividend Gr. 3/5Y | 9.74% 9.69% | Current Ratio | 2.27 | EPS Q/Q | 73.08% | SMA20 | -5.62% | Beta | 0.77 | Target Price | 142.00 |
| Payout | 19.70% | Debt/Eq | 0.47 | Sales Q/Q | 7.85% | SMA50 | -11.23% | Rel Volume | 0.79 | Prev Close | 129.91 |
| Employees | 1,200 | LT Debt/Eq | 0.48 | Earnings | Nov 04 | SMA200 | -11.70% | Avg Volume | 166.66K | Price | 130.98 |
| IPO Date | Mar 18, 1980 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -3.17% 0.72% | Net Debt/EBITDA | 1.43 | Volume | 131,121 | Change | 0.82% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-31-26 | Reiterated | Barclays | Equal Weight | $170 → $142 |
| Jun-30-26 | Initiated | Barclays | Equal Weight | $170 |
| Apr-14-25 | Upgrade | BWS Financial | Neutral → Buy | |
| Oct-16-24 | Downgrade | BWS Financial | Buy → Neutral | |
| Aug-07-23 | Upgrade | BWS Financial | Neutral → Buy |
Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition. The Industrial division supplies industrial-grade chemicals, associated products, and services to a diverse array of sectors, including agriculture, chemical processing, electronics, energy, food production, pharmaceuticals, and plating. Key offerings encompass acids, alkaline compounds, and food-grade and pharmaceutical-quality salts and components. Furthermore, this segment manages the receipt, storage, and distribution of various bulk chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. Manufacturing activities involve sodium hypochlorite, agricultural commodities, and a range of food-grade and pharmaceutical items like liquid phosphates, lactates, and custom blends. Additionally, the segment provides repackaging services for water treatment and bulk industrial chemicals, custom chemical blending, and contract and private-label packaging for bleach products. The Water Treatment division furnishes chemicals, equipment, and tailored solutions for applications in potable water, municipal and industrial wastewater management, industrial process water, and non-residential swimming pool and agricultural water systems. The Health and Nutrition division delivers ingredient procurement, processing, and formulation services to manufacturers specializing in nutraceuticals, functional foods and beverages, personal care items, dietary supplements, and other nutritional and health & wellness products. Its product portfolio features minerals, botanicals and herbal extracts, vitamins and amino acids, excipients, joint support products, sweeteners, and enzymes. The company, established in 1938, maintains its headquarters in Roseville, Minnesota.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2026 3/29/2026 | FY 2025 3/30/2025 | FY 2024 3/31/2024 | FY 2023 4/2/2023 | FY 2022 4/3/2022 | FY 2021 3/28/2021 | FY 2020 3/29/2020 | FY 2019 3/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,106 | 1,084 | 974 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 860 | 860 | 762 | — | — | — | — | — | — | |
| Gross Profit | 247 | 224 | 213 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 132 | 109 | 92 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Operating Income | 114 | 115 | 121 | — | — | — | — | — | — | |
| Interest Expense | 7 | 14 | 5 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 1 | 8 | -1 | — | — | — | — | — | — | |
| Net Income Before Taxes | 108 | 109 | 114 | — | — | — | — | — | — | |
| Income Taxes | 26 | 28 | 30 | — | — | — | — | — | — | |
| Consolidated Net Income | 80 | 82 | 84 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 80 | 82 | 84 | — | — | — | — | — | — | |
| Net Income | 80 | 82 | 84 | — | — | — | — | — | — | |
| EPS (Recurring) | 3.89 | 3.93 | 4.05 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.89 | 3.93 | 4.05 | — | — | — | — | — | — | |
| EPS (Diluted) | 3.86 | 3.91 | 4.03 | — | — | — | — | — | — | |
| EBITDA | 174 | 175 | 160 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 33.93 | 38.91 | 26.34 | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.49 | 2.95 | 2.29 | — | — | — | — | — | — | |
| Gross Margin | 22.33 | 20.66 | 21.87 | — | — | — | — | — | — | |
| Operating Margin | 10.31 | 10.61 | 12.42 | — | — | — | — | — | — | |
| Net Margin | 7.23 | 7.56 | 8.62 | — | — | — | — | — | — | |
| Shares Outstanding | 21 | 21 | 21 | — | — | — | — | — | — | |
| Market Capitalization | 2,751 | 3,195 | 2,229 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Faulconbridge James A | Director | Feb 05 '26 | Buy | 129.95 | 1,500 | 194,925 | 52,407 | Feb 06 |
| Faulconbridge James A | Director | Feb 04 '26 | Buy | 129.29 | 1,500 | 193,935 | 50,907 | Feb 06 |
| Grahek Drew M. | VICE PRESIDENT OF OPERATIONS | Nov 03 '25 | Buy | 126.34 | 1,587 | 200,506 | 39,640 | Nov 05 |
| Faulconbridge James A | Director | Jun 12 '24 | Buy | 89.94 | 1,800 | 161,899 | 47,817 | Jun 14 |
| Faulconbridge James A | Director | Jun 11 '24 | Buy | 89.05 | 2,000 | 178,099 | 46,017 | Jun 12 |
| Faulconbridge James A | Director | Jun 10 '24 | Buy | 86.47 | 2,000 | 172,937 | 44,017 | Jun 12 |
| Faulconbridge James A | Director | Jun 07 '24 | Buy | 87.53 | 1,500 | 131,294 | 42,017 | Jun 10 |
| Faulconbridge James A | Director | Jun 06 '24 | Buy | 87.56 | 1,800 | 157,612 | 40,517 | Jun 10 |
| Faulconbridge James A | Director | Jun 05 '24 | Buy | 86.57 | 600 | 51,942 | 38,717 | Jun 06 |
| Faulconbridge James A | Director | Jun 04 '24 | Buy | 86.50 | 1,300 | 112,454 | 38,117 | Jun 06 |
| Oldenkamp Jeffrey P. | Executive VP and CFO | Feb 11 '22 | Buy | 39.75 | 2,300 | 91,425 | 69,873 | Feb 15 |
| Lange Douglas A. | Vice President - Operations | Aug 21 '20 | Buy | 49.95 | 800 | 39,956 | 1,159 | Aug 26 |
| Moran Theresa R | VP - Purchasing, Logistics | Aug 21 '20 | Sale | 49.77 | 3,448 | 171,607 | 21,117 | Aug 25 |
| Moran Theresa R | VP - Purchasing, Logistics | Aug 13 '20 | Sale | 59.12 | 5,266 | 311,326 | 24,565 | Aug 17 |
| Stauber Daniel J | VP - Health and Nutrition | Nov 06 '18 | Buy | 37.69 | 2,000 | 75,380 | 7,394 | Nov 08 |